Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

452 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomy.
Tappero S, Sorce G, Hoeh B, Hohenhorst L, Panunzio A, Garcia CC, Piccinelli M, Tian Z, Parodi S, Montorsi F, Chun FKH, Graefen M, Antonelli A, Saad F, Shariat SF, De Cobelli O, Suardi NR, Borghesi M, Terrone C, Karakiewicz PI. Tappero S, et al. Among authors: de cobelli o. Can Urol Assoc J. 2023 Mar;17(3):E50-E56. doi: 10.5489/cuaj.8056. Can Urol Assoc J. 2023. PMID: 36473471 Free PMC article.
Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed?
Novara G, Ficarra V, Antonelli A, Artibani W, Bertini R, Carini M, Cosciani Cunico S, Imbimbo C, Longo N, Martignoni G, Martorana G, Minervini A, Mirone V, Montorsi F, Schiavina R, Simeone C, Serni S, Simonato A, Siracusano S, Volpe A, Carmignani G; SATURN Project-LUNA Foundation. Novara G, et al. Eur Urol. 2010 Oct;58(4):588-95. doi: 10.1016/j.eururo.2010.07.006. Epub 2010 Jul 23. Eur Urol. 2010. PMID: 20674150
Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysis.
Brookman-May S, May M, Shariat SF, Zigeuner R, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Feciche B, Coman I, Truss M, Pahernik S, Wirth MP, Zastrow S, Dalpiaz O, Fenske F, Waidelich R, Stief C, Gunia S; Members of the CORONA Project. Brookman-May S, et al. Among authors: de cobelli o, de nunzio c. Clin Genitourin Cancer. 2013 Dec;11(4):465-70. doi: 10.1016/j.clgc.2013.04.026. Epub 2013 Jun 29. Clin Genitourin Cancer. 2013. PMID: 23820063
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml.
Ferro M, Bruzzese D, Perdonà S, Marino A, Mazzarella C, Perruolo G, D'Esposito V, Cosimato V, Buonerba C, Di Lorenzo G, Musi G, De Cobelli O, Chun FK, Terracciano D. Ferro M, et al. Among authors: de cobelli o. PLoS One. 2013 Jul 4;8(7):e67687. doi: 10.1371/journal.pone.0067687. Print 2013. PLoS One. 2013. PMID: 23861782 Free PMC article.
Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).
Brookman-May SD, May M, Shariat SF, Novara G, Zigeuner R, Cindolo L, De Cobelli O, De Nunzio C, Pahernik S, Wirth MP, Longo N, Simonato A, Serni S, Siracusano S, Volpe A, Morgia G, Bertini R, Dalpiaz O, Stief C, Ficarra V; Members of the CORONA-Project; Members of the SATURN-Project; Young Academic Urologists Renal Cancer Group. Brookman-May SD, et al. Among authors: de cobelli o, de nunzio c. BJU Int. 2013 Nov;112(7):909-16. doi: 10.1111/bju.12246. Epub 2013 Jul 25. BJU Int. 2013. PMID: 23890378
Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience.
Ferro M, De Cobelli O, Buonerba C, Di Lorenzo G, Capece M, Bruzzese D, Autorino R, Bottero D, Cioffi A, Matei DV, Caraglia M, Borghesi M, De Berardinis E, Busetto GM, Giovannone R, Lucarelli G, Ditonno P, Perdonà S, Bove P, Castaldo L, Hurle R, Musi G, Brescia A, Olivieri M, Cimmino A, Altieri V, Damiano R, Cantiello F, Serretta V, De Placido S, Mirone V, Sonpavde G, Terracciano D. Ferro M, et al. Among authors: de berardinis e, de placido s, de cobelli o. Medicine (Baltimore). 2015 Oct;94(42):e1861. doi: 10.1097/MD.0000000000001861. Medicine (Baltimore). 2015. PMID: 26496339 Free PMC article.
The Prognostic Role of Circulating Tumor Cells (CTC) in High-risk Non-muscle-invasive Bladder Cancer.
Busetto GM, Ferro M, Del Giudice F, Antonini G, Chung BI, Sperduti I, Giannarelli D, Lucarelli G, Borghesi M, Musi G, de Cobelli O, De Berardinis E. Busetto GM, et al. Among authors: de berardinis e, de cobelli o. Clin Genitourin Cancer. 2017 Aug;15(4):e661-e666. doi: 10.1016/j.clgc.2017.01.011. Epub 2017 Jan 18. Clin Genitourin Cancer. 2017. PMID: 28188046
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study.
Ferro M, Vartolomei MD, Cantiello F, Lucarelli G, Di Stasi SM, Hurle R, Guazzoni G, Busetto GM, De Berardinis E, Damiano R, Perdonà S, Borghesi M, Schiavina R, Almeida GL, Bove P, Lima E, Grimaldi G, Autorino R, Crisan N, Abu Farhan AR, Verze P, Battaglia M, Serretta V, Russo GI, Morgia G, Musi G, de Cobelli O, Mirone V, Shariat SF. Ferro M, et al. Among authors: de berardinis e, de cobelli o. Urol Int. 2018;101(1):7-15. doi: 10.1159/000490765. Epub 2018 Jul 4. Urol Int. 2018. PMID: 29975950
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer.
Ferro M, Vartolomei MD, Russo GI, Cantiello F, Farhan ARA, Terracciano D, Cimmino A, Di Stasi S, Musi G, Hurle R, Serretta V, Busetto GM, De Berardinis E, Cioffi A, Perdonà S, Borghesi M, Schiavina R, Cozzi G, Almeida GL, Bove P, Lima E, Grimaldi G, Matei DV, Crisan N, Muto M, Verze P, Battaglia M, Guazzoni G, Autorino R, Morgia G, Damiano R, de Cobelli O, Shariat S, Mirone V, Lucarelli G. Ferro M, et al. Among authors: de berardinis e, de cobelli o. World J Urol. 2019 Mar;37(3):507-514. doi: 10.1007/s00345-018-2397-1. Epub 2018 Jul 10. World J Urol. 2019. PMID: 29992381
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer.
Vartolomei MD, Ferro M, Cantiello F, Lucarelli G, Di Stasi S, Hurle R, Guazzoni G, Busetto GM, De Berardinis E, Damiano R, Perdona S, Verze P, La Rocca R, Borghesi M, Schiavina R, Brunocilla E, Almeida GL, Bove P, Lima E, Grimaldi G, Autorino R, Crisan N, Abu Farhan AR, Battaglia M, Serretta V, Russo GI, Morgia G, Terracciano D, Musi G, de Cobelli O, Mirone V, Shariat SF. Vartolomei MD, et al. Among authors: de berardinis e, de cobelli o. Clin Genitourin Cancer. 2018 Dec;16(6):445-452. doi: 10.1016/j.clgc.2018.07.003. Epub 2018 Jul 6. Clin Genitourin Cancer. 2018. PMID: 30077463
452 results